Published in Cytokine on August 08, 2007
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun (2009) 3.00
Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity (2012) 2.08
Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol (2015) 1.24
Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm (2014) 1.16
Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine (2009) 1.08
Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav Immun (2011) 1.02
The aging kidney: increased susceptibility to nephrotoxicity. Int J Mol Sci (2014) 0.92
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders. Front Cell Neurosci (2015) 0.88
EGF signaling comes of age: promotion of healthy aging in C. elegans. Exp Gerontol (2010) 0.87
Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther (2014) 0.87
Identification of serum biomarkers for aging and anabolic response. Immun Ageing (2011) 0.86
Changes in gene expression associated with aging commonly originate during juvenile growth. Mech Ageing Dev (2010) 0.85
Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma. Exp Dermatol (2014) 0.84
Impact of age on markers of HIV-1 disease. Future Virol (2013) 0.82
Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case-control study. BMC Ophthalmol (2014) 0.82
Distinct roles of trauma and transfusion in induction of immune modulation after injury. Transfusion (2012) 0.80
Multiplex cytokine analysis of Werner syndrome. Intractable Rare Dis Res (2015) 0.78
Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest. Mediators Inflamm (2015) 0.77
Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity. Front Psychiatry (2017) 0.75
The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis. Biol Res (2015) 0.75
Selected life-extending interventions reduce arterial CXCL10 and macrophage colony-stimulating factor in aged mouse arteries. Cytokine (2017) 0.75
Mechanisms of skin aging induced by EGFR inhibitors. Support Care Cancer (2016) 0.75
Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin Oncol (2007) 3.05
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.90
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med (2008) 2.79
Development of a multimarker assay for early detection of ovarian cancer. J Clin Oncol (2010) 2.71
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial. J Clin Oncol (2007) 2.36
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clin Cancer Res (2007) 2.15
Cancer chemotherapy in the elderly patient. Oncology (Williston Park) (2010) 2.13
Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res (2011) 1.98
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol (2007) 1.75
Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res (2009) 1.73
A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening. J Thorac Oncol (2012) 1.63
Reproducibility of serum cytokines and growth factors. Cytokine (2008) 1.61
Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism. J Immunol (2009) 1.40
Dendritic cells in the cancer microenvironment. J Cancer (2012) 1.40
The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One (2009) 1.28
ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A (2010) 1.26
Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev (2006) 1.24
New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines (2010) 1.18
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw (2009) 1.16
Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp Cell Res (2009) 1.15
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control (2010) 1.14
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol (2009) 1.14
Aging and the dendritic cell system: implications for cancer. Crit Rev Oncol Hematol (2007) 1.13
Biological significance of prolactin in gynecologic cancers. Cancer Res (2009) 1.13
Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res (2007) 1.12
Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano (2011) 1.11
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res (2008) 1.09
Tumor associated regulatory dendritic cells. Semin Cancer Biol (2012) 1.08
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol (2004) 1.07
Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncol (2012) 1.05
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies. Clin Cancer Res (2008) 1.04
Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development. Lab Invest (2012) 1.04
Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc Natl Acad Sci U S A (2012) 1.04
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations. J Transl Med (2009) 1.03
Regulatory dendritic cells in the tumor immunoenvironment. Cancer Immunol Immunother (2011) 1.03
Multiple biomarker panels for early detection of ovarian cancer. Future Oncol (2006) 1.02
Role of eotaxin-1 signaling in ovarian cancer. Clin Cancer Res (2009) 1.01
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells. Cell Oncol (Dordr) (2011) 1.01
Small rho GTPases regulate antigen presentation in dendritic cells. J Immunol (2005) 1.00
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model. J Immunol (2013) 1.00
Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress. J Biol Chem (2007) 0.98
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner. J Immunotoxicol (2012) 0.98
Biomarker testing for ovarian cancer: clinical utility of multiplex assays. Mol Diagn Ther (2013) 0.96
Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays. J Neurosci Methods (2008) 0.96
Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Do serum biomarkers really measure breast cancer? BMC Cancer (2009) 0.95
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum Gene Ther (2006) 0.95
Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes (2010) 0.95
Immunological monitoring of the tumor immunoenvironment for clinical trials. Cancer Immunol Immunother (2011) 0.94
Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. Cancer Res (2010) 0.93
Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production. Exp Cell Res (2008) 0.93
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation. J Urol (2009) 0.93
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice. J Immunotoxicol (2012) 0.93
Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells. J Immunother (2008) 0.92
Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10. Int J Cancer (2002) 0.91
Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomark (2012) 0.91
Function and survival of dendritic cells depend on endothelin-1 and endothelin receptor autocrine loops. Blood (2004) 0.91
Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J Immunol (2005) 0.90
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer. J Urol (2008) 0.90
Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2. J Leukoc Biol (2002) 0.90
Clinical evaluation of systemic and local immune responses in cancer: time for integration. Cancer Immunol Immunother (2013) 0.89
Biodiesel versus diesel exposure: enhanced pulmonary inflammation, oxidative stress, and differential morphological changes in the mouse lung. Toxicol Appl Pharmacol (2013) 0.89
Carbon nanotubes enhance metastatic growth of lung carcinoma via up-regulation of myeloid-derived suppressor cells. Small (2012) 0.89
Factors associated with inflammation markers, a cross-sectional analysis. Cytokine (2011) 0.89
Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. J Exp Ther Oncol (2002) 0.88
Nano-gold corking and enzymatic uncorking of carbon nanotube cups. J Am Chem Soc (2015) 0.87
Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum. J Thorac Cardiovasc Surg (2008) 0.87
Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small (2012) 0.85
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSA. Adv Exp Med Biol (2007) 0.85
Targeting CCL11 in the treatment of ovarian cancer. Expert Opin Ther Targets (2010) 0.85
Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes. Am J Respir Cell Mol Biol (2013) 0.84
Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma. Exp Dermatol (2014) 0.84
Targeting myeloid regulatory cells in cancer by chemotherapeutic agents. Immunol Res (2011) 0.84
Immunological role of dendritic cells in cervical cancer. Adv Exp Med Biol (2007) 0.84
Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors. Prostate (2004) 0.83
Regulation of dendritic cell expansion in aged athymic nude mice by FLT3 ligand. Exp Gerontol (2004) 0.82
Optimizing dendritic cell-based immunotherapy for cancer. Expert Rev Vaccines (2007) 0.82